Javelin Biotech Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Javelin Biotech operates in the biotechnology research sector, developing predictive drug discovery systems that couple human biology data with computational analysis to shorten preclinical development timelines. This approach seeks to improve the likelihood that candidate therapies gain regulatory approval by more accurately translating early biological signals into translational insights. The company serves pharmaceutical and biotech organizations engaged in drug discovery, providing a pathway to bridge gaps between human biology and preclinical evaluation. It is based in Woburn, Massachusetts, and operates with a small team. A news item from October 2022 describes continued development of predictive platforms that pair human tissue-based assays with companion software to support translational research.